Business
Cell MedX Corp. Signs a Loan Agreement
Cell MedX Corp. Signs a Loan Agreement.
About this update from Stimcell Energetics Inc.
[{"type":"text","content":"\n \n \n Cell MedX Corp. Signs a Loan Agreement\n \n \nCell MedX Corp. Signs a Loan Agreement\n \n LAS VEGAS, NV--(Marketwired - Mar 9, 2016) - Cell MedX Corp. (OTCQB: CMXC) (\"Cell MedX\" or the \"Company\"), announces that on March 3, 2016 it has entered into a loan agreement (the \"Loan Agreement\") for a loan in the principal amount of $50,000 (the \"Loan\"). \n The Loan matures on March 3, 2017, with principal accumulating interest at a rate of 6% per annum. As additional consideration for the Loan, the Company issued to the lender share purchase warrants (the \"Warrants\") for the purchase of up to 2,000,000 shares of the Company's common stock, exercisable for a period of five years at a price of $0.15 per share if exercised during the first year, $0.25 per share if exercised during the second year, $0.40 per share if exercised during the third year, $0.60 per share if exercised during the fourth year and $0.75 per share during the fifth year.\n For further information on the Loan Agreement please refer to the Current Report on Form 8-K filed by the Company on March 9, 2016.\n About Cell MedX Corp. (OTCQB: CMXC)  \n Cell MedX Corp. is a development stage company focused on the commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications. For more information go to: www.cellmedx.com and visit us on Facebook. \n On behalf of the Board of Directors of Cell MedX Corp. \n Frank McEnulty\n Chief Executive Officer and President.\n Forward Looking Statements\n This press release contains forward-looking statements. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as \"expects,\" \"aims,\" \"intends,\" \"estimates,\" \"projects,\" \"anticipates,\" \"believes,\" \"could,\" \"possibility\" and other similar words. All statements addressing product performance, observations, studies, results, revenues, demand, events, or developments that the Company expects or anticipates will occur in the future are forward-looking statements. Because the statements are forward-looking, they should be evaluated in light of important risk factors and uncertainties, some of which are described in the Company's Quarterly, Annual and Current Reports filed with the United States Secu...